Topiramate: Difference between revisions
From SEHK Wiki
| Line 28: | Line 28: | ||
{| class = "wikitable" | {| class = "wikitable" | ||
!style="text-align: | !style="text-align: center"| For both adjunctive and monotherapy of epilepsy | ||
| By mouth | | By mouth | ||
ADULT: | ADULT: | ||
Revision as of 22:42, 5 October 2020
Introduction
Topiramate is a medication used to treat epilepsy and prevent migraines. For epilepsy this includes treatment for generalized or focal seizures. It is also used as adjunctive treatment for seizures associated with Lennox-Gastaut syndrome.
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Topiramate Tablet 25 mg | TOPI01 | P1S1S3 |
| Topiramate Tablet 50 mg | TOPI01 | P1S1S3 |
| Topiramate Tablet 100 mg | TOPI03 | P1S1S3 |
Mechanism of Action
Anticonvulsant medication. It inhibits the sodium channels, calcium channels, GABA-A receptors, and carbonic anhydrase isoenzymes, contributing to the antiseizure effects.
Dosage
| For both adjunctive and monotherapy of epilepsy | By mouth
ADULT:
|
|---|---|
For monotherapy, CHILD 6 – 17 years:
| |
As adjunctive therapy, CHILD form 2 years of age:
| |
| Migraine prophylaxis | By mouth
ADULT:
|
